Atlas Trials

Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder

Clinical trial NCT03625453 · COMPLETED

Trial details

NCT number
NCT03625453
Sponsor
Abide Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tourette SyndromeMotor Tic Disorder
Start date
2018-10-15
Primary completion
2020-01-20
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.